Long-Term Octreotide Therapy in Growth Hormone-Secreting Pituitary Adenomas:Evaluation with Serial MR
AJNR 18:765-772, Lundin,P.,et al, 1997
Acromegaly
NEJM 355:2558-2573, Melmed,S., 2006
Acromegaly
NEJM 322:966-977, Melmed,S., 1990
Diagnosis and Management of Pituitary Tumours
BMJ 308:1087-1091, Levy,A.&Lightman,S.L., 1994
Effect of Octreotide, A Somatostatin Analog, on Sleep Apnea in Patients with Acromegaly
Ann Int Med 121:478-483, Grunstein,R.R.,et al, 1994
Acromegaly:Treatment After 100 Years
BMJ 307:1505-1506, Wass,J.A.H., 1993
Octreotide and Graves'Ophthalmopathy and Pretibial Myxoedema
BMJ 304:158, Chang,T.C.,et al, 1992
Octreotide Treatment of Acromegaly, A Randomized, Multicenter Study
Ann Int Med 117:711-718, Ezzat,S.,et al, 1992
Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991
Reversal of a Neurologic Paraneoplastic Syndrome with Octreotide (Sandostatin) in a Pt with Glucagonoma
Am J Med 91:434-436, Holmes,A.,et al, 1991